baber/WOPTO huggingface dataset:
Patent CZ-283994-A3 (CZ)
Title: Fat-free beaten frozen dessert article
Inventor: LIPSCH MICHAEL HUBERTUS MARIA
IPC: A23G9/32
Filed: 1993-05-18
Abstract: PCT No. PCT/EP93/01275 Sec. 371 Date Jan. 23, 1995 Sec. 102(e) Date Jan. 23, 1995 PCT Filed May 18, 1993 PCT Pub. No. WO93/24019 PCT Pub. Date Dec. 9, 1993The invention relates to zero fat whipped frozen dessert products. Such products can be regarded as a low calorie alternative for ice cream. More in particular, the invention relates to zero fat whipped frozen dessert products having improved melting properties. Products showing a controlled melting behavior were obtained by using a specific emulsifier blend.
Patent CZ-290395-A3 (CZ)
Title: Analogs of vitamin d, their use and pharmaceutical compositions containing thereof
Inventor: HESSE ROBERT HENRY
IPC: A61P43/00
Filed: 1994-05-06
Abstract: Novel 1 alpha -hydroxy vitamin D derivatives and their 20-epi analogues, comprising compounds of general formula (I) where R<1> and R<2>, which may be the same or different, each represents a hydrogen atom or an aliphatic, cycloaliphatic, araliphatic or aryl group or together with the nitrogen atom to which they are attached form a heterocyclic group; R<3> represents a methyl group having  alpha - or  beta -configuration; X represents a valence bond or a C1-2 alkylene group; Y represents -O-, -S-, -CH2- or -NR- where R is a hydrogen atom or an organic group; Z represents a valence bond or a C1-3 alkylene group; and A= represents a cyclohexylidene moiety characteristic of the A-ring of a 1 alpha -hydroxylated vitamin D or analogue thereof, with the proviso that when -X-Y-Z- together represent an alkylene group containing up to 4 carbon atoms A= does not carry an exocyclic methylene group at the 10-position. Active compounds of the invention exhibit cell modulating activity while exhibiting a substantial lack of calcaemic effect.
Patent CZ-295498-A3 (CZ)
Inventor: MATTERN GERD
IPC: F41J3/02
Filed: 1996-12-18
Abstract: Zařízení Dart mána cílové oblasti rozdělenou hraď desku /1(V
Dart a displeje /12,14/, znázorňuje automatickyzjištěné zásahy.
Hrací deska/10/ Dartje pro alespoňjeden předemurčený časový
úsek volně spínatelná a umožňuje, že na zařízení Dartse mohou
hiát nové haní varianty.
Patent CZ-351395-A3 (CZ)
Title: Fine paper laminated fabric with softening components and a binder, and process for producing thereof
Inventor: PHAN DEAN VAN
IPC: D21H17/07
Filed: 1994-06-17
Abstract: Multi-layered tissue paper webs comprising chemical softener compositions and binder materials are disclosed. The multi-layered tissue webs are useful in the manufacture of soft, absorbent paper products such as facial tissues and/or toilet tissues. The multi-layered tissue paper products contain a chemical softening composition comprising a mixture of a quaternary ammonium compound and a polyhydroxy compound. Preferred quaternary ammonium compounds include dialkyl dimethyl ammonium salts such as di(hydrogenated)tallow dimethyl ammonium chloride, di(hydrogenated)tallow dimethyl ammonium methyl sulfate. Preferred polyhydroxy compounds are selected from the group consisting of glycerol, sorbitols, polyglycerols having a weight average molecular weight of from about 150 to about 800, polyoxyethylene glycols and polyoxypropylene glycols having a weight average molecular weight from about 200 to 4000. The multi-layered tissue paper webs also contain an effective amount of binder materials to control linting and/or to offset the loss in tensile strength, if any, resulting from the use of the chemical softening compositions. The binder materials are selected from the various wet and dry strength additives, and retention aids used in the paper making art. Preferably, the majority of the chemical softening compositions will be disposed on the outer layers of the multi-layered tissue paper products where they are most effective. The binder materials are typically dispersed throughout the multi-layered product to control linting. In other words, the chemical softening compositions and the binder materials can be selectively distributed within the multi-layered tissue paper web to enhance the softness, absorbency, and/or lint resistance of a particular layer or ply.
Patent CZ-353598-A3 (CZ)
Title: Method of increasing or inhibiting gene expression by making use of promoters of glutamate dehydrogenase, {beta}-n-hexosoanimidase gene and gamma-actin promoters and use of such promoters for preparing antibiotics
Inventor: BARREDO FUENTE JOSE LUIS
IPC: C12R1/66
Filed: 1998-03-05
Abstract: The invention relates to promoters of the genes glutamate desydrogenase,  beta -acetylhexosaminidase and  gamma -actine and their use in systems of expression, secretion and anti-sens of filamentary funghi. The invention also relates to the use of the promoters of the genes which code: (I) glutamate desydrogenase NADP depending (EC.1.4.1.4) of Penicillium chrysogenum, (II)  gamma -N-actylhexosaminidase (EC.3.2.1.52) of Penicillium chrysogenum and (III)  gamma -actine of Penicillium chrysogenum and Acrimonium chrysogenum, which can be used for the construction of potent vectors of expression and secretion useful both for P. chrysogenum and for A. chrysogenum and related species. Said promoters can also be used for blocking the genic expression through anti-sens construction. Under the control of the above mentioned promoters, it is possible to conduct the expression of other genes in filamentary fungi, thereby increasing the production of antibiotics and/or proteins inherent to the same.
Patent CZ-388497-A3 (CZ)
Title: Derivatives of heterocyclylcarboxamide and their use as therapeutic agents
Inventor: BIRCH ALAN MARTIN DR
IPC: A61K31/443
Filed: 1996-07-02
Abstract: PCT No. PCT/EP96/02890 Sec. 371 Date Jan. 5, 1998 Sec. 102(e) Date Jan. 5, 1998 PCT Filed Jul. 2, 1996 PCT Pub. No. WO97/03071 PCT Pub. Date Jan. 30, 1997Compounds of formula I and pharmaceutically acceptable salts thereof in which A is methylene or O; B is methylene or O; g is 0,1,2,3 or 4; R1 is an optional substituent; U is an alkylene chain optionally substituted by one or more alkyl; Q represents a divalent group containing nitrogen atoms; and T represents CO.HET, have utility in the treatment of central nervous system disorders, for example depression, anxiety, psychoses (for example schizophrenia), tardive dyskinesia, Parkinson's disease, obesity, hypertension, Tourette's syndrome, sexual dysfunction, drug addiction, drug abuse, cognitive disorders, Alzheimer's disease, senile dementia, obsessive-compulsive behavior, panic attacks, social phobias, eating disorders and anorexia, cardiovascular and cerebrovascular disorders, non-insulin dependent diabetes mellitus, hyperglycaemia, constipation, arrhythmia, disorders of the neuroendocrine system, stress, prostatic hypertrophy, and spasticity.
Patent CZ-390098-A3 (CZ)
Title: Hydroxyphosphinyl derivatives usable as naaladase inhibitors
Inventor: JACKSON PAUL F
IPC: C07F9/58
Filed: 1997-06-16
Abstract: The present disclosure relates to dipeptidase inhibitors, and more particularly, to novel phosphonate derivatives, hydroxyphosphinyl derivatives, and phosphoramidate derivatives that inhibit N-Acetylated  alpha -Linked Acidic Dipeptidase (NAALADase) enzyme activity, pharmaceutical compositions comprising such derivatives, and methods of using such derivatives to inhibit NAALADase activity, and to treat prostate diseases, especially using the compounds of the present invention for the inhibition of the growth of prostate cancer cells.
Patent SK-127693-A3 (SK)
Inventor: CERVENAK JAN
IPC: H01L27/00
Filed: 1993-11-17
Abstract: Materiál tvorí heterogénnu štruktúru. Pripravuje sa z
polovodičovej zlúčeniny systému AinB* v tepelným spracovaním
v oxidačnej atmosfére. Proces prípravy a
vlastnosti sú demonštrované na príklade spracovania
východiskovej polovodičovej zlúčeniny InSb a InSb (La)
v objemovom tvare, aj vo forme tenkého filmu na nosnej
podložke. V prípade napr. InSb ako vstupného materiálu
tepelným spracovaním v oxidačnej atmosfére
dochádza k fázovej konverzii tohto na heterogénnu
štruktúru obsahujúcu zložky ImOj-InSb-Sb. Priebeh elektrického
odporu takto obdržaného materiálu je daný
vzájomným pomerom týchto polovodičových zlúčenín a
kovových komponentov. Vzájomný pomer jednotlivých
komponentov zas závisí od stupňa tepelného spracovania
vstupného polovodičového materiálu v oxidačnej
atmosfére. Stupeň konverzie rastie s teplotou, dobou
záhrevu a koncentráciou kyslíka v oxidačnej atmosfére.
Prítomnosť 1 hmotn. prímesi La2O3 stupeň konverzie
podstatným spôsobom neovplyvnila.
Patent SK-128294-A3 (SK)
Title: Method of laser treatment of substrate, device for realization of this method and treated substrate
Inventor: FOLEY MICHAEL F
IPC: A23L3/26
Filed: 1993-04-27
Abstract: The present invention relates to a method of treating substrates for the purpose of reducing the population of contaminant organisms associated with them; particularly to treatment of foodstuffs, propagative materials and items intended for use in veterinary and medical applications. The method directs laser radiation at the substrate whereby the type and amount of laser radiation are selected such as to render organisms associated with the substrate inviable while leaving the desired properties of the substrate itself substantially unchanged. Apparatus suitable for treating a variety of substrates are disclosed, with a source of laser radiation (9, 28) and means (26, 27, 29) for handling the substrate (24). <IMAGE>
Patent SK-132395-A3 (SK)
Inventor: CITEK VLADIMIR
IPC: A01K1/08
Filed: 1995-10-24
Abstract: Tvoria ju vzájomne proti sebe prečnievajúce bočné
tvarované zábrany (I), vzájomne prepojené
šijovou zábranou (2). Priestor (6) lihacieho boxu
je tvorený bočnými tvarovanými zábranami (1),
ktorých horný koniec (8) je upevnený kotviacou
sponou (5) na strednú styčnú rúrku (4) a spodný
koniec (9) bočnej tvarovanej zábrany (1) je zakotvený
do státia (10) lihacieho boxu. Súčasne je
spojovacími sponami (3), na bočné tvarované zábrany
(1), nastaviteľné upevnená šijová zábrana
(2).
Patent SK-137193-A3 (SK)
Title: Process and device for producing leaven
Inventor: ISMAR THOMAS T
IPC: A21C1/00
Filed: 1992-05-30
Abstract: A process for producing leaven and a device especially suited to carrying out this process are to be improved in a way which ensures that a supply of leaven is constantly available in a quantity which can be predetermined and matched with the baking requirements, with only a modest technical outlay. This is accomplished according to the invention by placing the leaven preparation in an initial fermenter (2-4) in the fermenting chain and transferring it to the subsequent fermenter when a specific cycle time (t1-t4), which is the same for all the fermenters, has elapsed. Once the dough has passed through all the fermenters in the chain, it is transferred to a storage container (5); the sum of the cycle times (t1-t4) equals the total time of passage (tR) of the leaven.
Patent SK-164899-A3 (SK)
Title: Pharmaceutical composition, process for its production, and a composition
Inventor: PATEL JAI
IPC: A61K31/44
Filed: 1998-06-02
Abstract: A pharmaceutical composition comprising Compound (I), characterised in that the composition comprises 2 to 12 mg of Compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process.
Patent SK-272000-A3 (SK)
Title: Compounds derived from thiophene and benzothiophene, and related utilisation and composition
Inventor: MONGE VEGA ANTONIO
IPC: C07D333/32
Filed: 1998-07-01
Abstract: The compounds are of the general formula (I): <CHEM> where Z is: -CO-, -CH(OR6)-, -C(NOR7)-; R1 is: H, C1-C6 alkyl, halogen, or - OR12; R2 and R3 are: H, alkyl, halogen, nitro or -OR12, or R2 and R3 together are -C(R8) = C(R9)- C(R10) = C(R11)-; R4 and R5 are: H, alkyl, halogen, haloalkyl, -OR12, nitro, NR13R14; -COR12; CO2R12; -SO2NR13R14; -SO2R12; SR12, cyano; -CONR13R14 or R4 and R5 form a benzene ring; R6 is: H, alkyl, CO2R12, -C(O)NR13R14, naphthyl or phenyl; R7 is: H or alkyl; R8, R9, R10 and R11 are H, alkyl halogen, OR12, nitro, cyano, NR13R14, -COR12, CO2R12; - SO2NR13R14; -SO2R12; SR12, -CONR13R14; R12 is H, C1-C6 alkyl or phenyl; and R13 and R14 are H, alkyl or phenyl or R13 and R14 form a 5- or 6-membered ring. These compounds are effective for the treatment of anxiety or depression.
Patent SK-404692-A3 (SK)
Title: Method of phenol destruction
Inventor: SYKORA JAN
IPC: C02F1/32
Filed: 1992-12-31
Abstract: Solution is dealing of method of homogeneously catalysed thermic and photochemic destruction of phenol in aqueous- -acetonitrile medium by catalytic effect of bis (2,2'-bipyridine) cooper complexes. Base of solution is in fact, that solution £Cu(bpy)sub.2| exp.+ - phenol-acetonitril-water (£ACN|: : £H sub.2 O|=3:1 to 1:1) with concentrate Cu(I) 1.10 exp.-4 to 2.10 exp.-2 mol.dm exp.-3, phenol 1.10 exp.-4 to 1 mol.dm exp.-3 and mol ratio £Cu(I)| : £phenol| = 1:1 to 1:60 is bubbling through dioxygen by atmospheric pressure in glass reactor by 15 to 55 degrees of Celsius temperature in dark or during irradiation with polychromatic irradiate with wavelength longer than 320 nm during time longer than 30 minutes.
Patent BE-1002696-A3 (BE)
Title: Derives de dioxazocine, leur procede de preparation et compositions pharmaceutiques les contenant.
Inventor: ROZSA LASZLO
IPC: A61P25/20
Filed: 1988-12-30
Granted: 1991-05-07
Abstract: Dérivés de dioxazocine, leur préparation et des compositions les contenant, ces dérivés étant représentés par la formule (fig. 1) dans laquelle R1 représente un atome d'hydrogène ou un groupe alkyle ayant 1 à 4 atomes de carbone, R2 représente un groupe alkyle de 1 à 4 atomes de carbone, et n est égal à 0 ou 1, et leurs sels d'addition acides acceptables du point de vue pharmaceutique formés avec un acide inorganique ou organique. On décrit deux réactions différentes pour préparer ces composés. Ils peuvent être formulés en compositions pharmaceutiques de façon habituelle et ils présentent des activités touchant le système nerveux central.
Patent BE-1007775-A3 (BE)
Title: Magneetkop, voorzien van een kopvlak en een dunnefilm structuur, en werkwijze voor het vervaardigen van de magneetkop.
Inventor: VAN DER ZAAG PIETER J
IPC: G11B5/39
Filed: 1993-11-22
Granted: 1995-10-17
Abstract: Magneetkop, voorzien van een kopvlak (33) en een dunnefilm structuur met een magnetoweerstandselement (23) en een fluxgeleiden element (117a,117b) van een materiaal met een relatief hoge magnetische permeabiliteit. Een randgebied van het magnetoweerstandselement strekt zich tegenover het fluxgeleidende elementen uit, waarbij zich tussen het randgebied en het fluxgeleidende element een elektrisch isolerende, magnetisch permeabele tussenlaag (21) met een tussen 1.1 en 25 liggende relatieve magnetische permeabiliteit bevindt.
Patent BE-1008012-A3 (BE)
Title: Road marker cone
Inventor: LEVY LAURENT RAYMOND JOSEPH
IPC: E01F9/70
Filed: 1994-01-19
Granted: 1995-12-12
Abstract: A marker cone characterised in that it includes several road signprojections (1) connected to each other by a flexible link (2) the length ofwhich determines their maximum separation, these projections (1) beingfurthermore arranged in a movable way by sliding on a support (3).<IMAGE>
Patent BE-1010943-A3 (BE)
Title: Grijperweefmachine met een aantal geleidingsmiddelen.
IPC: D03D47/27
Filed: 1997-02-24
Granted: 1999-03-02
Abstract: Grijperweefmachine met een aantal geleidingsmiddelen (28) en geleidingsmiddelen (28) voor het geleiden van een grijperband (1,2), waarbij de geleidingsmiddelen (28) twee reeksen geleidingselementen (35,36) vormen, waarbij een eerste reeks samenwerkt met een eerste zijde (37) en een tweede reeks samenwerkt met een tweede zijde (38) van de onderkant van de grjperband (1,2) en waarbij alle geleidingselementen (35,36), minstens nabij de grijperband (1,2), zodanig naar de grijperband (1,2) toe gericht zijn dat, naar het riet (13) toe, een stompe hoek (B,B',C,C') gevormd wordt tussen deze geleidingselementen (35,36) en de grijperband (1,2).
Patent WO-9717859-A3 (WO)
Inventor: DE SOUSA NETO JOAQUIM FRANCISC
IPC: A43B23/00
Filed: 1996-11-12
Abstract: A tennis shoe which holds a multifunction microcomputer (1) which is fixed through the length of the tread, and that works activated by the weavers body weight over a switch (8) placed inside the shoe sole (7).
Patent WO-9204170-A3 (WO)
Title: Methode de fabrication d'objets a partir de materiaux en poudre
Inventor: HOLL RICHARD A
IPC: B28B3/00
Filed: 1991-09-04
Abstract: On mélange et l'on homogénéise des matériaux pâteux, à partir desquels des pièces à l'état vert sont moulées avant d'être frittées, et qui autrement seraient difficiles, voire impossibles, à mélanger à l'état pâteux, en formant une masse que l'on place entre deux plateaux parallèles de surface plane et que l'on aplatit entre ces deux plateaux jusqu'à ce qu'elle devienne une fine galette; on remodèle ensuite ladite galette en une masse ou une boule en remontant ses bords externes vers le centre. Ce cycle de compression-mélange est répété plusieurs fois jusqu'à la fin du processus, à savoir de 10 à 50 fois généralement, et normalement de 20 à 30 fois. Des objets en céramique moulée ayant des surfaces 'à finition brillant' sont ainsi produits de façon économique en mettant à profit une faible déformation de cisaillement superplastique, 5 % au moins, produite par le moulage des objets ayant leurs surfaces de finition en contact avec les surfaces de moule ayant le fini requis. La taille des particules des matériaux céramiques en poudre avec lesquels on commence à travailler est de l'ordre du micron ou moins, et les pièces à l'état vert moulées sont formées grâce à des techniques de malaxage, broyage et mélange qui conservent l'uniformité des matériaux et maintiennent la taille des particules en dessous du micron. Les pièces à l'état vert sont frittées par frittage à vitesse contrôlée aifn de maintenir la taille des grains en dessous de la valeur d'un micron nécessaire à la forgeabilité dans le domaine superplastique. Les pièces frittées sont ensuite moulées comme décrit ci-dessus à une température minimum de 0,5 M, M représentant la température de fusion des matériaux céramiques.
Patent WO-9731107-A3 (WO)
Title: Apoptose induite par des lectines de serum humain et procede de detection d'apoptose
Inventor: COLES JOHN G
IPC: C12N15/12
Filed: 1997-02-19
Abstract: Le thème directeur de la présente invention est la description d'une classe de protéines présentes dans le sang humain, lesquelles ont la capacité de reconnaître et d'induire sélectivement l'apoptose de cellules portant des glucides de surface anormaux. Des modifications de la glycosilation cellulaire peuvent résulter de différences spécifiques d'espèces ou peuvent refléter des changements associés à un cancer. On a isolé des protéines liant un glucide de sérum humain, appelées lectines, sur différentes colonnes de glucide, notamment Gal alpha (papGal), GalNAc, GlcNAc, fucose, mannose et mélibiose. On a démontré que ces lectines provoquent l'apoptose de cellules endothéliales aortiques porcines. Ceci démontre une nouvelle voie conduisant à la mort de cellules endothéliales après un stress xénogène pouvant être important dans la pathogénèse du rejet d'hétérogreffes et suggère de nouvelles approches thérapeutiques dans le traitement du rejet d'hétérogreffes. De plus, ces protéines de liaison de glucides mammifères sont ici présentées comme étant la cause de l'apoptose de cellules in vitro du cancer du sein et du cancer des poumons et elles peuvent être utilisées en tant qu'agent cytotoxique contre des cellules tumorales humaines. De manière significative, les protéines de la présente invention présentent une liaison ou une réactivité minimale contre des cellules humaines glycosilées de façon normale. Cette invention concerne également un nouveau dosage biologique de détection et de quantification de l'apoptose cellulaire in vitro, ainsi que l'utilité de ce dosage pour l'identification et l'évaluation de composés présentant une activité apogénique potentielle.
Patent CU-22303-A3 (CU)
Title: Procedure for the synthesis of new fluoronaphthacenodions.
Inventor: GIOLITTI ALESSANDREO
IPC: A61K31/122
Filed: 1990-11-13
Abstract: New 7-substituted fluoro-2 beta -acetyl-2 alpha ,4 alpha ,5,12-tetrahydroxy-1,2,3,4-tetrahydro-6,11-naphthacenedion es having the general formula I: <CHEM> where X is a hydrogen atom, or a hydroxyl group, R and R1, which cannot be equal, are a hydrogen atom or a fluorine atom; R2 can be hydrogen atom or a hydroxyl group or an alkoxy group. These fluoro-naphthacenediones can be useful for obtaining new derivatives which show a different reactivity of the 2 alpha  hydroxyl, in particular new anthracyclines.
Patent CZ-2002739-A3 (CZ)
Title: Pharmaceutical preparation intended for treating hepatocellular carcinoma
Inventor: CHI CHIN-WEN
IPC: A61K9/08
Filed: 2000-08-29
Abstract: The present invention is based on the finding that docetaxel is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 muM. It accordingly provides the use of docetaxel, or a hydrate thereof, in the manufacture of a medicament for use in the treatment of hepatocellular carcinoma.
Patent CZ-2002996-A3 (CZ)
Inventor: FOUS JAROSLAV
IPC: B23Q1/25
Filed: 2002-03-20
Abstract: Hydrostatická komora je vytvořena na jedné ze vzájemně se
posouvajících součástí (1, 2), kupříkladu na plochách vedení
saní obráběcího stroje, a sestává z přívodu (P) a odvodu (O)
maziva, které se nacházejí uvnitř plochy (3) ohraničené
drážkou (11) s těsněním (4) uloženým v drážce (11) vytvořené
v horní součásti (1). Těsnění (4) přiléhá k protilehlé součásti
(2), přičemž uvnitř plochy (3) ohraničené těsněním (4) je
vytvořeno radiální vybrání (31), které ohraničuje středový
výstupek (32), kterýje opatřen odvodem (O) a radiální
vybrání (31) přívodem (P) maziva.
Patent CZ-2006373-A3 (CZ)
Inventor: BOHACEK JOSEF
IPC: B60W10/00
Filed: 2006-06-13
Abstract: Integrovaný ovladac (1) sestává z rucního ovladace (2), který má dva stupne volnosti, pricemž je pres táhlo (3) spojen s telesem rozdelovace (4), ve kterém jsou usporádány ovládací prvky pro ovládánírejdu (D), brzd (B) a akcelerace (A). Pohybové zmeny ovládání ovladace (1) jsou v proporcionálním vztahu k funkcím pro všechny napojené rízené okruhyvozidla což jsou systém rejdu (D), brzd (B) a akcelerace (A), pricemž všechny úkony pro mobilitu vozidla jsou sdruženy do jednoho ovladace pro jednu horní koncetinu.